Neervannan Seshadri
Insider CIK 1827584 · TARS Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-04 | 2026-09-09 | 4,564 | $85.00 | $387.9K | 78,532 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-04 | 2026-09-09 | 4,564 | $85.00 | $387.9K | 78,532 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-20 | 2026-03-24 | 2,989 | $66.75 | $199.5K | 82,791 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-19 | 2026-03-19 | 4,589 | $67.00 | $307.5K | 85,780 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-18 | 2026-03-19 | 3,610 | $68.71 | $248.0K | 90,369 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-17 | 2026-03-19 | 3,125 | $69.42 | $216.9K | 93,979 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 5,097 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 5,022 | — | $0 | 15,067 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 8,148 | — | $0 | 8,148 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 8,020 | — | $0 | 16,040 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2026-03-15 | 2026-03-17 | 26,287 | — | $0 | 97,104 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 27,310 | — | $0 | 27,310 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 17,161 | — | $0 | 17,161 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-04 | 2026-03-05 | 8,366 | $76.67 | $641.4K | 70,817 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | G Gift | 2025-12-16 | 2025-12-18 | 950 | — | $0 | 79,183 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | G Gift | 2025-12-16 | 2025-12-18 | 475 | — | $0 | 475 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-20 | 2025-03-20 | 2,435 | $50.11 | $122.0K | 79,682 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-19 | 2025-03-20 | 2,543 | $47.40 | $120.5K | 82,117 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-18 | 2025-03-20 | 2,605 | $46.29 | $120.6K | 84,660 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-15 | 2025-03-18 | 5,097 | — | $0 | 5,097 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-15 | 2025-03-18 | 8,019 | — | $0 | 24,060 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-15 | 2025-03-18 | 8,148 | — | $0 | 16,296 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2025-03-15 | 2025-03-18 | 21,264 | — | $0 | 87,265 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-03-05 | 2025-03-07 | 20,089 | — | $0 | 20,089 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-03-05 | 2025-03-07 | 30,628 | — | $0 | 30,628 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2024-03-18 | 2024-03-19 | 4,879 | $30.60 | $149.3K | 64,767 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2024-03-15 | 2024-03-19 | 5,097 | — | $0 | 10,194 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2024-03-15 | 2024-03-19 | 8,148 | — | $0 | 24,444 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2024-03-15 | 2024-03-19 | 13,245 | — | $0 | 69,646 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-03-07 | 2024-03-11 | 47,500 | — | $0 | 47,500 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-03-07 | 2024-03-11 | 32,079 | — | $0 | 32,079 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-23 | 2023-03-23 | 390 | $12.15 | $4.7K | 54,696 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-22 | 2023-03-23 | 379 | $12.64 | $4.8K | 55,086 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-21 | 2023-03-23 | 372 | $12.89 | $4.8K | 55,465 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-20 | 2023-03-21 | 380 | $12.61 | $4.8K | 55,837 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-17 | 2023-03-21 | 360 | $13.28 | $4.8K | 56,217 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-17 | 357 | $13.43 | $4.8K | 56,577 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2023-03-15 | 2023-03-17 | 5,097 | — | $0 | 15,291 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2023-03-15 | 2023-03-17 | 5,097 | — | $0 | 56,934 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-03-08 | 2023-03-10 | 48,116 | — | $0 | 48,116 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-03-08 | 2023-03-10 | 32,592 | — | $0 | 32,592 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-03-09 | 2022-03-11 | 69,498 | — | $0 | 69,498 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-03-09 | 2022-03-11 | 20,388 | — | $0 | 20,388 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2021-01-07 | 2021-01-08 | 61,499 | — | $0 | 61,499 | SEC↗ |